|
|
|
| home > white papers > Crossing the Blood Brain Barrier (BBB): Which Route to Take? - Aptar Pharma |
|
|
 WHITE PAPERS |
|
Aptar Pharma
|
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
|
|
Aptar Pharma recently hosted an expert panel/roundtable on the various
approaches to treating central nervous system (CNS) diseases. This
international scientific forum was held in Paris, France on December
5th, 2014. The roundtable was organized to explore and exchange views on
the challenges, approaches and opportunities that exist with regard to
effectively crossing the blood brain barrier (BBB) and successfully
treating a host of CNS diseases.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PPMA Group Industry Awards 2018 Call for Entries – Deadline 31st July
The PPMA Group Industry Awards,
which recognise manufacturing excellence, technical innovation,
entrepreneurship as well as outstanding achievement and contribution to
the industry, will this year take place at a new venue – the Hilton
Birmingham Metropole Hotel at the NEC - on the 25th September 2018.
More info >> |
|
 |
White Papers |
 |
|
R&D to Product: How to Reduce Costly Scale-Up Problems
Natoli Engineering Company, Inc.
When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >> |
|
 |
Industry Events |
 |
SAPHEX 2018
1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa
The SAPHEX exhibition and conference is now established as the “go-to”
networking and business event for anyone working in the South African
pharmaceutical manufacturing industry.
More info >> |
|
|
|
